§Why CasetextPricing

Foreign-Trade Zone (FTZ) 22; Authorization of Production Activity; AbbVie, Inc.; (Pharmaceutical Products); North Chicago, Illinois

89 Fed. Reg. 80452 (Oct. 3, 2024)

Foreign-Trade Zone (FTZ) 22; Authorization of Production Activity; AbbVie, Inc.; (Pharmaceutical Products); North Chicago, Illinois

Download PDF
Federal RegisterOct 3, 2024
89 Fed. Reg. 80452 (Oct. 3, 2024)
Document Headings

Document headings vary by document type but may contain the following:

  • the agency or agencies that issued and signed a document
  • the number of the CFR title and the number of each part the document amends, proposes to amend, or is directly related to
  • the agency docket number / agency internal file number
  • the RIN which identifies each regulatory action listed in the Unified Agenda of Federal Regulatory and Deregulatory Actions

    • See the Document Drafting Handbook for more details.

    Department of Commerce Foreign-Trade Zones Board
  • [B-32-2024]

    • On May 31, 2024, AbbVie, Inc. submitted a notification of proposed production activity to the FTZ Board for its facilities within Subzone 22S, in North Chicago, Illinois.

    The notification was processed in accordance with the regulations of the FTZ Board (15 CFR part 400), including notice in the Federal Register inviting public comment (89 FR 51495, June 18, 2024). On September 30, 2024, the applicant was notified of the FTZ Board's decision that no further review of the activity is warranted at this time. The production activity described in the notification was authorized, subject to the FTZ Act and the FTZ Board's regulations, including section 400.14.

    Dated: September 30, 2024.

    Elizabeth Whiteman,

    Executive Secretary.

    [FR Doc. 2024-22826 Filed 10-2-24; 8:45 am]

    BILLING CODE 3510-DS-P